Literature DB >> 19545651

Familial Sotos syndrome caused by a novel missense mutation, C2175S, in NSD1 and associated with normal intelligence, insulin dependent diabetes, bronchial asthma, and lipedema.

Ulrich Zechner1, Nicolai Kohlschmidt, Olga Kempf, Konstanze Gebauer, Karsten Haug, Hartmut Engels, Thomas Haaf, Oliver Bartsch.   

Abstract

We report a familial Sotos syndrome in two children, boy and girl, aged 17 and 8 years, and in their 44 year old mother, who displayed normal intelligence at adult age, but suffered from insulin dependent diabetes mellitus, bronchial asthma, and severe lipedema. The underlying missense mutation, C2175S, occurred in a conserved segment of the NSD1 gene. Our findings confirm that familial cases of SS are more likely to carry missense mutations. This case report may prove useful to avoid underestimation of the recurrence rate of SS, and to demonstrate that the developmental delay may normalize, enabling an independent life and having an own family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545651     DOI: 10.1016/j.ejmg.2009.06.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

Review 1.  Cognition and Behaviour in Sotos Syndrome: A Systematic Review.

Authors:  Chloe Lane; Elizabeth Milne; Megan Freeth
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

2.  A Novel Missense Mutation of the NSD1 Gene Associated with Overgrowth in Three Generations of an Italian Family: Case Report, Differential Diagnosis, and Review of Mutations of NSD1 Gene in Familial Sotos Syndrome.

Authors:  Gianluigi Laccetta; Francesca Moscuzza; Angela Michelucci; Andrea Guzzetta; Sara Lunardi; Francesca Lorenzoni; Paolo Ghirri
Journal:  Front Pediatr       Date:  2017-11-07       Impact factor: 3.418

Review 3.  Lipedema: A Call to Action!

Authors:  Giacomo Buso; Michele Depairon; Didier Tomson; Wassim Raffoul; Roberto Vettor; Lucia Mazzolai
Journal:  Obesity (Silver Spring)       Date:  2019-10       Impact factor: 5.002

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.